Acknowledgement
This work was supported by 2019 grant from The Korean Society of Ginseng.
References
- Burns A, Iliffe S. Alzheimer's disease. BMJ 2009;338:b158. https://doi.org/10.1136/bmj.b158
- Li N, Liu Y, Li W, Zhou L, Li Q, Wang X, He P. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease. J Ginseng Res. 2016;40:9-17. https://doi.org/10.1016/j.jgr.2015.04.006
- Zadori D, Veres G, Szalardy L, Klivenyi P, Vecsei L. Alzheimer's disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and Kynurenines. J Alzheimers Dis 2018;62:523-47. https://doi.org/10.3233/JAD-170929
- Association As. 2018 Alzheimer's disease facts and figures. Alzheimer's Dementia 2018;14:367-429. https://doi.org/10.1016/j.jalz.2018.02.001
- Hu Z, Wang L, Ma S, Kirisci L, Feng Z, Xue Y, Klunk WE, Kamboh MI, Sweet RA, Becker J, et al. Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimer's Dementia: Translational Research & Clinical Interventions 2018;4:542-55. https://doi.org/10.1016/j.trci.2018.09.001
- Kwan KKL, Yun H, Dong TTX, Tsim KWK. Ginsenosides attenuate bioenergetics and morphology of mitochondria in cultured PC12 cells under the insult of amyloid beta-peptide. J Ginseng Res 2020;45:473-81.
- Bagyinszky E, Giau VV, Shim K, Suk K, An SSA, Kim S. Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis. J Neurol Sci 2017;376:242-54. https://doi.org/10.1016/j.jns.2017.03.031
- Hroudova J, Singh N, Fisar Z. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease. BioMed Res Int 2014;2014:175062. https://doi.org/10.1155/2014/175062
- Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD. The role of reactive oxygen species in the pathogenesis of Alzheimer's disease, Parkinson's disease, and Huntington's disease: a mini review. Oxidative Med Cell Longev 2016;2016:8590578. https://doi.org/10.1155/2016/8590578
- Zadori D, Veres G, Szalardy L, Klivenyi P, Toldi J, Vecsei L. Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets. J Alzheimers Dis 2014;42(Suppl 3):S177-87. https://doi.org/10.3233/JAD-132621
- Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 2016;167:1469-80. e12. https://doi.org/10.1016/j.cell.2016.11.018
- He Y, Kosciolek T, Tang J, Zhou Y, Li Z, Ma X, Zhu Q, Yuan N, Yuan L, Li C, et al. Gut microbiome and magnetic resonance spectroscopy study of subjects at ultra-high risk for psychosis may support the membrane hypothesis. Eur Psychiatr 2018;53:37-45. https://doi.org/10.1016/j.eurpsy.2018.05.011
- Gulden E, Chao C, Tai N, Pearson JA, Peng J, Majewska-Szczepanik M, Zhou Z, Wong FS, Wen L. TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells. J Autoimmun 2018;93:57-65. https://doi.org/10.1016/j.jaut.2018.06.003
- Li YY, Pearson JA, Chao C, Peng J, Zhang X, Zhou Z, Liu Y, Wong FS, Wen L. Nucleotide-binding oligomerization domain-containing protein 2 (Nod 2) modulates T1DM susceptibility by gut microbiota. J Autoimmun 2017;82:85-95. https://doi.org/10.1016/j.jaut.2017.05.007
- Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 2017;5:14. https://doi.org/10.1186/s40168-016-0222-x
- Peng J, Xiao X, Hu M, Zhang X. Interaction between gut microbiome and cardiovascular disease. Life Sci 2018;214:153-7. https://doi.org/10.1016/j.lfs.2018.10.063
- Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, Du L, Cao Q, Tang J, Zhou C, et al. A metagenomic study of the gut microbiome in Behcet's disease. Microbiome 2018;6:135. https://doi.org/10.1186/s40168-018-0520-6
- Jiang C, Li G, Huang P, Liu Z, Zhao B. The gut microbiota and Alzheimer's disease. J Alzheimers Dis 2017;58:1-15. https://doi.org/10.3233/JAD-161141
- Sochocka M, Donskow-Lysoniewska K, Diniz BS, Kurpas D, Brzozowska E, Leszek J. The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer's disease-a critical review. Mol Neurobiol 2019;56:1841-51. https://doi.org/10.1007/s12035-018-1188-4
- Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 2014;6. 263ra158. https://doi.org/10.1126/scitranslmed.3009759
- Rybnikova E. Brain, antibiotics, and microbiota - how do they interplay? J Neurochem 2018;146:208-10. https://doi.org/10.1111/jnc.14341
- Kim J-H. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. J Ginseng Res 2018;42:264-9. https://doi.org/10.1016/j.jgr.2017.10.004
- Kim KH, Lee D, Lee HL, Kim C-E, Jung K, Kang KS. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res 2018;42:239-47. https://doi.org/10.1016/j.jgr.2017.03.011
- Fang F, Chen X, Huang T, Lue LF, Luddy JS, Yan SS. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochim Biophys Acta 2012;1822:286-92. https://doi.org/10.1016/j.bbadis.2011.10.004
- Xie X, Wang HT, Li CL, Gao XH, Ding JL, Zhao HH, Lu YL. Ginsenoside Rb1 protects PC12 cells against β-amyloid-induced cell injury. Mol Med Rep 2010;3:635-9. https://doi.org/10.3892/mmr_00000308
- Wu J, Yang H, Zhao Q, Zhang X, Lou Y. Ginsenoside Rg1 exerts a protective effect against Aβ25-35-induced toxicity in primary cultured rat cortical neurons through the NF-κB/NO pathway. Int J Mol Med 2016;37:781-8. https://doi.org/10.3892/ijmm.2016.2485
- Kim HJ, Jung SW, Kim SY, Cho IH, Kim HC, Rhim H, Kim M, Nah SY. Panax ginseng as an adjuvant treatment for Alzheimer's disease. J Ginseng Res. 2018;42:401-11. https://doi.org/10.1016/j.jgr.2017.12.008
- Wan Y, Wang J, J-f Xu, Tang F, Chen L, Tan Y-z, et al. Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects. J Ginseng Res 2021;45:617-30. https://doi.org/10.1016/j.jgr.2021.03.001
- Wang N, Wang X, He M, Zheng W, Qi D, Zhang Y. Han C-c. Ginseng polysaccharides: a potential neuroprotective agent. J Ginseng Res 2020;45:211-7.
- Im K, Kim J, Min H. Ginseng, the natural effectual antiviral: protective effects of Korean Red Ginseng against viral infection. J Ginseng Res 2016;40:309-14. https://doi.org/10.1016/j.jgr.2015.09.002
- Kim D, Kwon S, Jeon H, Ryu S, Ha KT, Kim S. Proteomic change by Korean Red Ginseng in the substantia nigra of a Parkinson's disease mouse model. J Ginseng Res. 2018;42:429-35. https://doi.org/10.1016/j.jgr.2017.04.008
- Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6. https://doi.org/10.1038/nmeth.f.303
- Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. Microbiome Analyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res 2017;45. W180-w8. https://doi.org/10.1093/nar/gkx295
- DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-72. https://doi.org/10.1128/AEM.03006-05
- Kohler CA, Maes M, Slyepchenko A, Berk M, Solmi M, Lanctot KL, Carvalho AF. ^ The gut-brain Axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in Alzheimer's disease. Curr Pharmaceut Des 2016;22:6152-66. https://doi.org/10.2174/1381612822666160907093807
- Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK. Microbiome-microglia connections via the gut-brain axis. J Exp Med 2018;216:41-59. https://doi.org/10.1084/jem.20180794
- Tang W, Zhu H, Feng Y, Guo R, Wan D. The impact of gut microbiota disorders on the blood-brain barrier. Infect Drug Resist 2020;13:3351-63. https://doi.org/10.2147/IDR.S254403
- Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, Jin L, Chen X. The progress of gut microbiome research related to brain disorders. J Neuroinflammation 2020;17:25. https://doi.org/10.1186/s12974-020-1705-z
- Bonfili L, Cecarini V, Gogoi O, Gong C, Cuccioloni M, Angeletti M, et al. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease. FEBS J 2020;288:2836-55 [n/a].
- Kowalski K, Mulak A. Brain-gut-microbiota Axis in Alzheimer's disease. J Neurogastroenterol Motil 2019;25:48-60. https://doi.org/10.5056/jnm18087
- Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 2014;6. 263ra158. https://doi.org/10.1126/scitranslmed.3009759
- Takeshita Y, Fujikawa S, Omoto M, Shimizu F, Maeda T, Sano Y, Kanda T. The effect of blood-brain barrier (BBB)-specific laminins for barrier function with a new in vitro BBB model incorporating multi-culturing system of BBB components. J Neurol Sci 2017;381:966.